ARTICLES BY BRIAN CLARK
-
![Complex Antibody-Drug Conjugate Supply Chains: To Integrate or Not?]( "Complex Antibody-Drug Conjugate Supply Chains: To Integrate or Not?")
Complex Antibody-Drug Conjugate Supply Chains: To Integrate or Not?5/29/2018The number of critical components in the antibody-drug conjugate (ADC) production process creates one of the most complex supply challenges in the biopharmaceutical industry. The decision to go with one or more CDMOs is the start of a partnership that will be key to the success of an ADC product.
Brian Clark
Brian Clark is principal at GMP Operations Consulting LLC, a CMC consulting firm founded in 2006. He has more than 25 years of experience in the development, manufacturing, and quality management of biologics, drugs, and medical devices, with specific expertise in advanced technology medicinal products such as cell therapies, regenerative medicine, and antibody-drug conjugates. Previously, he served in executive and senior leadership roles at ImmunoGen Inc., Altus Pharmaceuticals, Alkermes, Therion Biologics, Antigenics (now Agenus), and Genzyme Tissue Repair. Brian has a bachelor’s in biology from the University of Massachusetts, Boston, and an MBA in general management from Boston University.